Fingerprint
Dive into the research topics where Nynke Kalkers is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
Low natalizumab trough concentrations are associated with reduced seroconversion of the John Cunningham virus in natalizumab-treated patients with multiple sclerosis
Gelissen, L. M. Y., Toorop, A. A., Schipper, P. M., Hoitsma, E., Zeinstra, E. M. P. E., Van Rooij, L. C., Van Munster, C. E. P., Vennegoor, A., Mostert, J., Wokke, B., Kalkers, N. F., Hoogervorst, E. L. J., Van Eijk, J., Roosendaal, C. M., Kragt, J. J., Eurelings, M., Van Genugten, J., Nielsen, J., Sinnige, L. G. F. & Kloosterziel, M. E. & 11 others, , 1 Nov 2025, In: Journal of Neurology, Neurosurgery and Psychiatry. 96, 11, p. 1038-1045 8 p.Research output: Contribution to journal › Article › Academic › peer-review
Open AccessFile21 Downloads (Pure) -
Reliability of serum neurofilament light and glial fibrillary acidic protein for detecting disease activity upon discontinuation of first-line disease-modifying therapy in stable multiple sclerosis (DOT-MS)
Fung, W. H., Wessels, M. H. J., Coerver, E. M. E., de Beukelaar, J., Bouvy, W. H., Canta, L. R., Gerlach, O. H. H., Hoitsma, E., Hoogervorst, E. L. J., de Jong, B. A., Kalkers, N. F., van Kempen, Z. L. E., Lövenich, H., van Munster, C. E. P., van Oosten, B. W., Smolders, J., Vennegoor, A., Zeinstra, E. M. P. E., Barrantes-Cepas, M. & Kooij, G. & 9 others, , Aug 2025, In: Journal of neurology. 272, 8, 530.Research output: Contribution to journal › Article › Academic › peer-review
Open AccessFile24 Downloads (Pure) -
Discontinuation of First-Line Disease-Modifying Therapy in Patients With Stable Multiple Sclerosis: The DOT-MS Randomized Clinical Trial
Coerver, E. M. E., Fung, W. H., de Beukelaar, J., Bouvy, W. H., Canta, L. R., Gerlach, O. H. H., Hoitsma, E., Hoogervorst, E. L. J., de Jong, B. A., Kalkers, N. F., van Kempen, Z. L. E., Lövenich, H., van Munster, C. E. P., van Oosten, B. W., Smolders, J., Vennegoor, A., Zeinstra, E. M. P. E., Barrantes-Cepas, M., Kooij, G. & Schoonheim, M. M. & 8 others, , 9 Dec 2024, (E-pub ahead of print) In: JAMA Neurology.Research output: Contribution to journal › Article › Academic › peer-review
Open AccessFile22 Downloads (Pure) -
Influence of personalized extended interval dosing on the natalizumab wearing-off effect - a sub-study of the NEXT-MS trial
Toorop, A. A., Wessels, M. H. J., Gelissen, L. M. Y., Hoitsma, E., Zeinstra, E. M. P. E., van Rooij, L. C., van Munster, C. E. P., Vennegoor, A., Mostert, J. P., Wokke, B. H. A., Kalkers, N. F., Hoogervorst, E. L. J., van Eijk, J. J. J., Roosendaal, C. M., Kragt, J. J., Eurelings, M., van Genugten, J., Nielsen, J., Sinnige, L. G. F. & Kloosterziel, M. E. & 11 others, , 15 Jul 2024, In: Journal of the neurological sciences. 462, p. 123102 123102.Research output: Contribution to journal › Article › Academic › peer-review
Open AccessFile26 Downloads (Pure) -
Serum neurofilament light and glial fibrillary acidic protein levels are not associated with wearing-off symptoms in natalizumab-treated multiple sclerosis patients
Toorop, A. A., Wessels, M. H. J., Boonkamp, L., Gelissen, L. M. Y., Hoitsma, E., Zeinstra, E. M. P., van Rooij, L. C., van Munster, C. E. P., Vennegoor, A., Mostert, J. P., Wokke, B. H. A., Kalkers, N. F., Hoogervorst, E. L. J., van Eijk, J. J. J., Roosendaal, C. M., Kragt, J. J., Eurelings, M., van Genugten, J., Nielsen, J. & Sinnige, L. G. F. & 12 others, , Nov 2024, In: Multiple Sclerosis Journal. 30, 13, p. 1683-1688 6 p.Research output: Contribution to journal › Article › Academic › peer-review
Open AccessFile28 Downloads (Pure)